Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00005584 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 5 versions Re-verified since Jul 26, 2017, no change to tracked fieldsv17-v21
  2. Enrollment target: 1649
    • Primary completion date: May 2004
    v16
  3. Interventions: ABVD regimen (Drug), BEACOPP regimen (Drug), bleomycin sulfate (Biological), epirubicin hydrochloride (Drug), prednisone (Drug), radiation… to ABVD regimen (Drug), BEACOPP regimen (Drug), bleomycin sulfate (Biological), epirubicin hydrochloride (Drug), prednisone (Drug), radiation…v15
  4. Re-verified, no change to tracked fieldsv14
  5. Publications: 9 to 10v13
Show 11 earlier versionsHide 11 earlier versions
  1. Interventions: ABVD regimen (Drug), BEACOPP regimen (Drug), bleomycin (Biological), epirubicin hydrochloride (Drug), prednisone (Drug), radiation therapy… to ABVD regimen (Drug), BEACOPP regimen (Drug), bleomycin sulfate (Biological), epirubicin hydrochloride (Drug), prednisone (Drug), radiation…v12
  2. Interventions: ABVD regimen (Drug), BEACOPP regimen (Drug), bleomycin (Drug), epirubicin hydrochloride (Drug), prednisone (Drug), radiation therapy… to ABVD regimen (Drug), BEACOPP regimen (Drug), bleomycin (Biological), epirubicin hydrochloride (Drug), prednisone (Drug), radiation therapy…v11
  3. Interventions: bleomycin (Drug), epirubicin hydrochloride (Drug), prednisone (Drug), radiation therapy (Procedure), vinblastine (Drug) to ABVD regimen (Drug), BEACOPP regimen (Drug), bleomycin (Drug), epirubicin hydrochloride (Drug), prednisone (Drug), radiation therapy…v10
  4. Re-verified, no change to tracked fieldsv9
  5. Interventions: bleomycin (Drug), chemotherapy (Procedure), epirubicin hydrochloride (Drug), prednisone (Drug), radiation therapy (Procedure), vinblastine… to bleomycin (Drug), epirubicin hydrochloride (Drug), prednisone (Drug), radiation therapy (Procedure), vinblastine (Drug)v8
  6. Publications revised (9)v7
  7. Publications revised (9)v6
  8. Re-verified, no change to tracked fieldsv5
  9. Publications: 8 to 9v4
  10. Start date: Oct 1998v3 Show 4 more changesShow less
    • Interventions: bleomycin (Drug), chemotherapy (Procedure), epirubicin (Drug), prednisone (Drug), radiation therapy (Procedure), vinblastine (Drug) to bleomycin (Drug), chemotherapy (Procedure), epirubicin hydrochloride (Drug), prednisone (Drug), radiation therapy (Procedure), vinblastine…
    • Study description expanded, about 93 words
    • Publications: 2 to 8
    • Eligibility criteria expanded, about 5 words
  11. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage cancer cells. Combining chemotherapy with radiation therapy may kill more cancer cells. It is not yet known which combination chemotherapy regimen is most effective in treating Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to compare the effectiveness of different regimens of combination chemotherapy with or without radiation therapy in treating patients who have Hodgkin's lymphoma.
Trial Details
NCT Number NCT00005584
Lead Sponsor European Organisation for Research and Treatment of Cancer - EORTC
Collaborators: Lymphoma Study Association, UNICANCER
Conditions
(from sponsor)		 Lymphoma
Related terms Hodgkin Disease, Lymphoma
Enrollment 1,649 participants
Start Date
Primary Completion (estimated)
Updated on ClinicalTrials.gov